Inventor
DUGI KLAUS
DE17 patents
⚠️ This page may combine multiple inventors who share the name “DUGI KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DUGI KLAUS
9 patentsUS8551957B2Oct 8, 2013
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate
DUGI KLAUS53 citations98
US8232281B2Jul 31, 2012
Uses of DPP-IV inhibitors
DUGI KLAUS110 citations98
US8673927B2Mar 18, 2014
Uses of DPP-IV inhibitors
DUGI KLAUS63 citations97
US8846695B2Sep 30, 2014
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor
DUGI KLAUS49 citations93
US9457029B2Oct 4, 2016
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
DUGI KLAUS29 citations92
US9173859B2Nov 3, 2015
Uses of DPP IV inhibitors
DUGI KLAUS27 citations92
US8853156B2Oct 7, 2014
Treatment for diabetes in patients inappropriate for metformin therapy
DUGI KLAUS28 citations90
US9486526B2Nov 8, 2016
Treatment for diabetes in patients inappropriate for metformin therapy
DUGI KLAUS11 citations81
US8202884B2Jun 19, 2012
Treatment of type 2 diabetes
DUGI KLAUS2 citations56
BOEHRINGER INGELHEIM INT
7 patentsUS10092571B2Oct 9, 2018
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
BOEHRINGER INGELHEIM INT9 citations82
US10034877B2Jul 31, 2018
Treatment for diabetes in patients inappropriate for metformin therapy
BOEHRINGER INGELHEIM INT11 citations82
US7524822B2Apr 28, 2009
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
BOEHRINGER INGELHEIM INT9 citations81
US12171767B2Dec 24, 2024
Uses of DPP IV inhibitors
BOEHRINGER INGELHEIM INT0 citations62
US11291668B2Apr 5, 2022
Uses of DPP IV inhibitors
BOEHRINGER INGELHEIM INT0 citations62
US12312352B2May 27, 2025
Use of a DPP-4 inhibitor in SIRS and/or sepsis
BOEHRINGER INGELHEIM INT0 citations61
US10080754B2Sep 25, 2018
Uses of DPP IV inhibitors
BOEHRINGER INGELHEIM INT0 citations52